170 related articles for article (PubMed ID: 35905838)
1. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Eugster PJ; Maurer J; Vocat C; Abid K; Matter M; Wuerzner G; Trepp R; Fischli S; Henzen C; Kolb W; Bilz S; Sigrist S; Beuschlein F; Nölting S; Reul A; Schütze I; Hubers SA; Brown NJ; Grouzmann E
Clin Chim Acta; 2022 Sep; 534():146-155. PubMed ID: 35905838
[TBL] [Abstract][Full Text] [Related]
2. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
3. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.
Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA
Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581
[TBL] [Abstract][Full Text] [Related]
5. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
[TBL] [Abstract][Full Text] [Related]
6. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
7. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
8. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
9. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
10. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
11. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS.
Vocat C; Dunand M; Hubers SA; Bourdillon N; Millet GP; Brown NJ; Wuerzner G; Grouzmann E; Eugster PJ
Anal Chem; 2020 Jan; 92(1):859-866. PubMed ID: 31790196
[TBL] [Abstract][Full Text] [Related]
13. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
14. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
[TBL] [Abstract][Full Text] [Related]
15. Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma.
Lin Y; Wang M; Cao Y
Ann Clin Biochem; 2023 May; 60(3):160-168. PubMed ID: 36653315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure-suppressant actions of prepro-NPY overexpression in male rats.
Soud K; Jørgensen SH; Woldbye DPD; Sørensen AT
J Neurosci Res; 2019 Mar; 97(3):362-372. PubMed ID: 30367522
[TBL] [Abstract][Full Text] [Related]
18. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.
Xiong X; Zhang Y
Anal Bioanal Chem; 2020 May; 412(12):2763-2775. PubMed ID: 32130439
[TBL] [Abstract][Full Text] [Related]
19. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
[TBL] [Abstract][Full Text] [Related]
20. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
